Lilium (NASDAQ:LILM – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $2.00 price objective on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 162.30% from the company’s previous close.
Separately, Canaccord Genuity Group restated a “buy” rating and set a $2.00 price objective on shares of Lilium in a report on Thursday, June 27th.
Check Out Our Latest Research Report on Lilium
Lilium Stock Performance
Hedge Funds Weigh In On Lilium
Hedge funds and other institutional investors have recently bought and sold shares of the business. XTX Topco Ltd purchased a new position in shares of Lilium during the 2nd quarter valued at approximately $25,000. Warberg Asset Management LLC acquired a new stake in shares of Lilium in the 2nd quarter worth $27,000. RS Crum Inc. acquired a new stake in shares of Lilium in the 2nd quarter worth $328,000. Longitude Cayman Ltd. increased its stake in shares of Lilium by 12.2% in the 2nd quarter. Longitude Cayman Ltd. now owns 1,514,672 shares of the company’s stock worth $1,204,000 after acquiring an additional 164,672 shares during the last quarter. Finally, Financial Designs Corp acquired a new stake in shares of Lilium in the 2nd quarter worth $32,000. Institutional investors and hedge funds own 8.30% of the company’s stock.
About Lilium
Lilium N.V. engages in the research and development of electric vertical takeoff and landing aircrafts and jet for use in high-speed air transport system for people and goods. It also provides aircraft manufacturer services, including training services, maintenance operations, material management and global distribution, flight operations support, ground service equipment, and digital solutions.
Read More
- Five stocks we like better than Lilium
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Where Do I Find 52-Week Highs and Lows?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Lilium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lilium and related companies with MarketBeat.com's FREE daily email newsletter.
